$JUNS Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease https://www.biospace.com/press-releases/jupiter-neurosciences-receives-fda-clearance-of-ind-application-to-initiate-phase-2a-clinical-trial-of-jotrol-in-parkinsons-disease